Day: January 23, 2024

Vancouver, British Columbia, Jan. 23, 2024 (GLOBE NEWSWIRE) — AISIX Solutions Inc., (“AISIX” or “the Company”) (TSXV: AISX) (OTCQB: AISXF) (FSE: QT7), an emerging global climate risk and data analytics solutions provider, is pleased to announce its strategic plans for 2024. The Company is focused on a continued commitment to innovation, providing advanced data analysis and comprehensive services to business partners across Canada and globally. AISIX’s Journey So Far Over the last six years, AISIX has invested more than $10M in the development of artificial intelligence expertise, innovative research, and proprietary data sets — resulting in a suite of enterprise products capable of supporting clients across the world in an era of changing climate and increased risk. 2023 AchievementsThe Company released a beta version of the...

A Sensational Blend of Music and Winemaking Crafted with Grammy-Nominated Artist Jeremih and Renowned Winemaker Russell Bevan LiveOne Enters $40B White Wine Market LOS ANGELES, CA, Jan. 23, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – LiveOne, Inc. (NASDAQ: LVO), a leading creator-first platform, proudly announces the launch of Birthday Sex Wine, a one-of-a-kind collaboration with Grammy-nominated R&B artist Jeremih and acclaimed Napa Valley/Sonoma winemaker Russell Bevan. The exclusive pre-sale opened last Friday with a limited quantity of the product’s first run and has already sold out. Additional inventory is expected to be added to the product’s website in the coming weeks. Inspired by Jeremih’s chart-topping debut hit single, “Birthday Sex,” Birthday Sex Wine is a Naked Chardonnay meticulously handpicked...

This award recognizes SP+’s impact and commitment to delivering on Our Promise: Making Every Moment Matter, for a World on the Go CHICAGO, Jan. 23, 2024 (GLOBE NEWSWIRE) — SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announced its recognition as one of America’s Greatest Workplaces for Diversity 2024 by Newsweek and Plant-A Insights Group. This survey of over 220,000+ individuals included representation at over 1.5 million companies in America. “Diversity is a widely discussed topic, and it remains a crucial factor as people look for an employer or a business partner,” said Nancy Cooper, Global Editor in-Chief, Newsweek. “Newsweek and market-data research...

– University of Utah Hospital, Lori Gawron, M.D. of the Obstetrics and Gynecology (OB/GYN) Department, was an instrumental investigator in Femasys’ earlier FemBloc study – – FemBloc is being developed as a first-of-its-kind, non-surgical permanent birth control with a clear U.S. regulatory pathway – ATLANTA, Jan. 23, 2024 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced that it has activated enrollment for its pivotal FemBloc trial at another academic site, University of Utah Hospital in Salt Lake City, Utah. The FemBloc Intratubal Occlusion for...

NEW YORK, Jan. 23, 2024 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware and services, today announced that it has notified the Nasdaq Stock Market (“Nasdaq”) that it expects to file a Form 10-K/A for the year ended December 31, 2022 with restated financial statements, as well as Forms 10-Q/A for the quarters ended March 31, 2023 and June 30, 2023 and a Form 10-Q for the quarter ended September 30, 2023 by no later than February 28, 2024. The Company also plans to file its Form 10-K for the year ended December 31, 2023 by the March 2024 due date. In a press release dated November 29, 2023, the Company previously announced that it had received a standard notification letter from the Listing Qualifications Department of Nasdaq...

Expanding Reach into 1000s of Stores in Hispanic Communities BARTLETT, Tenn., Jan. 23, 2024 (GLOBE NEWSWIRE) — SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecom company focused on the underbanked and underserved communities, announced today that it has entered into a distribution agreement with SIN PIN, a telecommunications service provider to immigrant communities in the US, which we believe will drive wireless subscriber growth in the Hispanic community. President of SurgePays, Jeremy Gies, said, “SIN PIN provides us thousands of distribution points to service immigrant populations beyond the traditional convenience store. We believe these stores represent a fantastic opportunity to increase our wireless subscriber base significantly. With over 150 team members working at our operations center...

LOS ALAMITOS, Calif. and LAS VEGAS, Jan. 23, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the visionary force behind MARKET.live, the innovative multi-vendor, multi-presenter, livestream social shopping platform, proudly announces the addition of five more distinctive retail brands to its livestream social shopping platform. The addition of these retailers evidences MARKET.live’s continuing growth and dedication to curating a diverse range of products for its growing community.  Meet the Newest Additions to MARKET.live: GF PET Notable: Explore an extensive range of pet products designed for quality and style at GF PET.Companion Candles Notable: Immerse yourself in the captivating world of fragrances with artisanal candles at Companion Candles.Zadro...

SOLANA BEACH, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced new research published in the peer-reviewed Journal of Pain. The research article, titled “Discovery and preclinical evaluation of a novel inhibitor of FABP5, ART26.12, effective in Oxaliplatin-induced Peripheral Neuropathy,” highlights Artelo’s pre-clinical asset, ART26.12, and its potential ability to treat and prevent Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in a series of separate studies. ART26.12 is a Fatty Acid Binding Protein 5 (FABP5) inhibitor in development for the treatment of chemotherapy-induced peripheral neuropathy (CIPN),...

Figure 1:Location of the newly acquired Terraza Project (purple highlights), together with Mirador, Solario and Ventana Projects, and location of key prospective stratigraphy in the region.Figure 2:Overview of Latin Metals’ copper interests in Argentina, including the newly acquired Terraza copper project in Juyay Province, the Solario, Ventana and Mirador copper projects in Salta Province, and the advanced Esperanza copper-gold porphyry project in San Juan Province.VANCOUVER, British Columbia, Jan. 23, 2024 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF), a leading mineral exploration company in South America, announces acquisition by staking of the 68,000-hectare Terraza copper exploration project (Figures 1 and 2) in northwest Argentina. Latin...

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 11,872,397 relating to the Company’s non-invasive, frequency-based deep brain stimulation device.  The newly-issued patent, entitled “Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System,” covers the core technology utilized in the Company’s Gen-3 system, a proprietary and advanced waveform device that is designed to treat patients in a painless and undetectable manner. The Gen-3 system reflects state-of-the-art development of Nexalin’s Deep Intracranial Frequency Stimulation (DIFS®) technology, and a significant advancement to the predecessor Gen-1 system.  The Company’s technology uses...